论文部分内容阅读
目的分析重症肌无力合并甲状腺机能亢进患者临床特点及治疗路径。方法选取2013年8月~2014年9月我院神经内科收治的52例重症肌无力合并甲状腺机能亢进患者作为临床研究对象，结合患者病情特点同步给予两病同治方案，观察患者临床症状改善情况。结果52例患者经临床定向治疗后，患者甲状腺功能、重症肌无力临床症状均得到了良性改善，整体治疗效果显著。结论针对重症肌无力合并甲状腺机能亢进患者临床治疗，通过给予两病同治方案，可有效改善患者病情，提升患者生活质量。“,”Objective To analyze myasthenia gravis merger hyperthyroidism patients clinical characteristics and treatment paths.Methods Selection in August 2013 to September 2014 department of neurology were analyzed during the period of 52 patients with myasthenia gravis hyperthyroidism merger as a clinical research object,combining with the characteristics of patients synchronous gives two development schemes,patients with clinical symptoms was observed.Results 52 patients with clinical orientation after treatment,patients with thyroid function,clinical symptoms of myasthenia gravis were benign improved,the overal treatment ef ect is remarkable.Conclusion For myasthenia gravis patients with hyperthyroidism clinical treatment,by giving two development scheme,which can ef ectively improve the patients,improve the treatment of patients with life.